All lobbying filings

BROWNSTEIN HYATT FARBER SCHRECK, LLP

BROWNSTEIN HYATT FARBER SCHRECK, LLP filed a Q2 report for ELANCO ANIMAL HEALTH on July 20, 2026, reporting $40,000 in lobbying income.

Lobbying for ELANCO ANIMAL HEALTH · Animal pharmaceutical company

All filings by BROWNSTEIN HYATT FARBER SCHRECK, LLP · Everything ELANCO ANIMAL HEALTH has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Income

$40,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Advocacy surrounding the development of pharmaceuticals for animals

Tariff (miscellaneous tariff bills)

Advocacy surrounding tariff exclusions regarding pharmaceuticals for animals

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem